Human interferon and its applications
Boiron, M.; Marty, M.
Semaine des Hopitaux. Therapeutique 53(3): 185-187
1977
ISSN/ISBN: 0302-9271 PMID: 877594 Document Number: 124097
Document emailed within 1 workday
Related Documents
Nagao, S.; Nakano, A.; Moritake, K.; Morikawa, S.; Harada, T. 1997: Synergistic antitumor effects of human interferon-beta and interferon-gamma on human gastric adenocarcinoma cells Human Cell 10(1): 95-104Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Rubin, B.Y.; Bartal, A.H.; Anderson, S.L.; Millet, S.K.; Hirshaut, Y.; Feit, C. 1983: The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon Journal of Immunology 130(3): 1019-1020
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171
Avdeeva, Z.I.; Mazina, N.M.; Vakhromeeva, N.S.; Krylov, O.P.; Moskalenko, M.B.; Medunitsyn, N.V. 1990: The immunomodulating action of interferon preparations. 3. Changes in the phagocytic activity of human blood neutrophilic granulocytes under the influence of interferon preparations Vestnik Dermatologii i Venerologii 8: 23-28
Finbloom, D.S.; Hoover, D.L.; Wahl, L.M. 1985: The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines Journal of Immunology 135(1): 300-305
Stancek, D.; Fuchsberger, N.; Oltman, M.; Schmeisser, H.; Kontsek, P.; Jahnová, E.; Hajnická, V. 2001: Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virologica 45(5-6): 287-292
Takahashi, N.; Mundy, G.R.; Roodman, G.D. 1986: Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells Journal of Immunology 137(11): 3544-3549
Han, Z.C.; Briere, J.; Abgrall, J.F.; Le Gall, G.; Parent, D.; Sencebe, L. 1987: Effects of recombinant human interferon alpha on human megakaryocyte and fibroblast colony formation Journal of Biological Regulators and Homeostatic Agents 1(4): 195-200
Timofeev, I.V.; Kuznetsov, V.P.; Slavina, E.G.; Timofeeva, T.P.; Orlova, T.G. 1982: Effect of various forms of human leukocyte interferon on the natural killer activity of human lymphocytes Antibiotiki 27(10): 782-784
Imanishi, J.; Tanaka, A.; Matsuoka, H. 1984: Inhibition of the multiplication of human herpes virus i by prostaglandin D2 and the synergistic effect of human leukocyte interferon Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 178(6): 671-674
Náray-Fejes-Tóth, A.; Guyre, P.M. 1984: Recombinant human immune interferon induces increased IgE receptor expression on the human monocyte cell line U-937 Journal of Immunology 133(4): 1914-1919
Nagao, S.; Tohgo, A.; Kohno, M.; Ogawa, H. 1983: Cytostatic action of human fibroblast interferon in direct growth inhibition: effect on human malignant melanoma Gan 74(3): 452-458
Brosjö, O.; Bauer, H.C.; Broström, L.A.; Nilsson, O.S.; Reinholt, F.P.; Tribukait, B. 1987: Growth inhibition of human osteosarcomas in nude mice by human interferon-alpha: significance of dose and tumor differentiation Cancer Research 47(1): 258-262
Mauerhoff, T.; Belfiore, A.; Pujol-Borrell, R.; Bottazzo, G.F. 1994: Growth inhibition of human endothelial cells by human recombinant tumor necrosis factor alpha and interferon-gamma Tumori 80(4): 301-305
Kase, S.; Kubota, T.; Watanabe, M.; Furukawa, T.; Tanino, H.; Kuo, T.H.; Saikawa, Y.; Teramoto, T.; Kitajima, M. 1995: Recombinant human interferon alpha-2a increases the antitumor activity of 5-fluorouracil on human colon carcinoma xenograft Co-4 without any change in 5-FU pharmacokinetics Anticancer Research 15(1): 153-155
Cornetta, K.; Berebitsky, D.; Behnia, M.; Traycoff, C.; Srour, E.F.; Sledge, G.W. 1994: A retroviral vector expressing human interferon gamma upregulates MHC antigen expression in human breast cancer and leukemia cell lines Cancer Gene Therapy 1(2): 91-98
Yamamoto, K.; Mizutani, Y.; Nakanishi, H.; Fujiwara, J.; Ishida, H.; Toiyama, D.; Abe, K.; Hayashi, I.; Okada, K.; Kawauchi, A.; Mizuno, M.; Yoshida, J.; Miki, T. 2008: Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma International Journal of Oncology 33(3): 565-571
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908